TLR2 and Parkinson disease: Specifically, TLR2 and TLR4 are repeatedly implicated in PD, with reported changes in receptor levels or signalling in people with PD, a central role in neurodegeneration in animal models, and molecular interactions with α-synuclein in vitro.